Following Women's Health Over Time After Obesity Treatment
Follows women in obesity treatment, tracking nutrition, muscle, reproductive health and pregnancy.
Plain-language title generated from the registry record
Registry title: Monitoring Nutritional Consequences of Obesity Treatment on Women's Health
Key facts
- Where
- Elst, NetherlandsSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 55 years old?
Source: NCT06945016, who can take part
Where in Netherlands
- Rijnstate Elst, VitalysElst, NetherlandsTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Wageningen University and Research
- Trial code
- NCT06945016
- Record updated
- 10 July 2025
- Original description
The goal of this observational study is to investigate the long-term effect of obesity treatments on the health of women. This study will specifically focusses on the effects on nutritional intake, nutritional status, musculoskeletal health and reproductive health. Additionally, this study will also investigate the effect of obesity treatment on pregnancy outcomes and child development.Read full original descriptionShow less
MOnitoring NUtritional COnsequences of Obesity Treatment on Women's Health and Transgenerational Effects for Healthier Future Generations: a Multicentre Prospective Observational Cohort Study
The goal of this observational study is to investigate the long-term effect of obesity treatments on the health of women. This study will specifically focusses on the effects on nutritional intake, nutritional status, musculoskeletal health and reproductive health. Additionally, this study will also investigate the effect of obesity treatment on pregnancy outcomes and child development.
To achieve the goal of this study, participants already receiving either surgical treatment for obesity or treatment with anti-obesity medication as part of their regular medical care will fill in additional questionnaires, provide blood, urine and feces samples, and undergo additional measurements of body composition and muscle strength up to for 10 years.
General Inclusion Criteria:; Female sex at birth; Aged 18-55 years of age; Living with obesity (BMI ≥ 30 kg/m2); Approved for obesity treatment in one of the participating hospitals:; Undergoing primary bariatric surgery (RYGB, OAGB or SG); Receiving obesity medication (any type) with a BMI ≥30 kg/m2 under medical supervision; For those undergoing MRI, DEXA and quantitative ultrasound scan: Willing to be informed about incidental findings of pathology and approving of reporting this to their general physician; Additional inclusion criteria for birth cohort:; Being pregnant; Age 18-45 years of age; Having received prior obesity treatment, either surgical (RYGB, OAGB, SG) or pharmacological for at least 4 months under medical supervision (any type); General Exclusion Criteria:; Male sex at birth; Aged <18 or >55 years of age; BMI <30 kg/m2; Not able to read and/or write in Dutch; Undergoing a revisional or secondary bariatric procedure (excluding previous gastric banding); Malnutrition due to other chronic condition, specifically malignancy, substance abuse; (mental) condition that makes it impossible to fill out a questionnaire correctly; For those undergoing a DEXA scan: height >196 cm or weight >160 kg; For those undergoing a MRI scan: having a contra-indication to MRI scanning including (but not limited to) pacemakers and defibrillators, intraorbital or intraocular metallic fragments, ferromagnetic implans or claustrophobia; Additional exclusion criteria birth cohort:; Aged <18 or >45 years of age; >25 weeks of gestation; Multiple pregnancy; Reversal of the bariatric procedure.